Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$12.98 - $17.1 $4.8 Million - $6.32 Million
-369,748 Reduced 4.34%
8,144,760 $110 Million
Q4 2022

Feb 14, 2023

BUY
$13.92 - $17.0 $119 Million - $145 Million
8,514,508 New
8,514,508 $132 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.